SPARK Europe Webinar Series | 12 October 2022 | 4-5 pm (CET)
Dr. René Bernard “EQIPD- a Quality Management System with Industrial Standards for Preclinical Research”
Quality Management Systems have transformed industries over the past decades – with one exception: preclinical research.
EQIPD QS was developed by several industrial, academic and CRO partners within an IMI-funded project to ensure preclinical data quality, validity and traceability. It can be applied to all research in an industry setting and ideally, to academic labs seeking collaboration with industry partners. The registered association GoEQIPD e.V. acts as guarantor of the quality system ensuring its actuality, its independence and overall awareness of research quality.
In this SPARK Europe Webinar Series, Dr. René Bernard, coordinator for Value and Open Science at the NeuroCure Excellence Cluster Berlin, will explain the hallmarks and latest developments of the EQIPD QS. René has worked as a scientist with preclinical research for several years in academic and industrial settings, co-developed the EQIPD QS and acts now as GoEQIPD board member. After this talk, you will know about:
- Why can it be useful to consider quality management in preclinical research?
- What are the advantages and benefits of EQIPD QS and EQIPD certification?
- What is the EQIPD framework?
Online via MS Teams ǀ Please register here!
The webinar will be hosted by SPARK-BIH.
Contact:
Dr. Vera Martos Riaño
vera.martos-riano@bihealth.de
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
